Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia

Tae Kon Kim, Mina L. Xu, Nikolai A. Podoltsev, Thomas Prebet, Lisa Barbarotta, Kejal Amin, Stephanie Kasberg, Kristen Roche, Maximilian Stahl, Steven D. Gore, Amer M. Zeidan

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia'. Together they form a unique fingerprint.